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Introduction
Storage of erythrocytes for transfusion purposes
is accompanied by a number of morphological and
biochemical changes, the storage lesions. Some of
these lesions, such as the almost complete, fast
disappearance of 2,3-diphoshosphoglycerate and the
relatively small, slow decrease in intracellular ATP,
may be reversible. Other changes, such as the loss of
haemoglobin, and of phospholipid and protein by
vesiculation, are not1. Especially the irreversible
lesions are likely to affect erythrocyte survival and
function after transfusion. Elucidation of the
underlying mechanisms may not only result in
prolonged storage times, but also - and probably more
importantly - in a higher quality of the erythrocyte
transfusion product. One of the first requirements for
a higher quality is prolonged survival time in vivo or,
more specifically, a higher fraction of erythrocytes
that survive the first 24 hours after transfusion. The
data of recent studies, that used minor blood group
antigens and compared the survival characteristics of
various products in one and the same recipient,
indicate that the percentage erythrocytes that is
removed within a few hours after transfusion may be
as high as 30%2. This fraction does not only represent
nonfunctional erythrocytes, but also may be a major
factor in the interaction between the transfused
erythrocyte and the patient's immune system. The
resulting pathological reactions may cause long-term
transfusion side effects such as the development of
anti-erythrocyte antibodies, especially in transfusion-
dependent patients, and in patients with a chronic
inflammation3-6.
Since the pivotal studies showing that
physiological removal of old erythrocytes is initiated
by their specific recognition by the immune system7,
it has become obvious to apply the knowledge of
causes and effects of the aging process in vivo to the
study of the changes that erythrocytes undergo during
storage, an aging process in vitro. In fact, in one of
the first attempts to mimick the physiological aging
process, storage in blood bank-like conditions was
the treatment that yielded the most complete set of
biologically relevant aging parameters then available8.
These parameters were concentrated on structural and
functional changes in band 3, the anion exchanger
and major protein of the erythrocyte membrane:
increased breakdown as deduced from immunoblot
patterns and decreased anion transport capacity as
deduced from sulfate exchange characteristics8. Since
then, our knowledge on composition and insight in
the organisation of the erythrocyte membrane and the
role of band 3 therein has vastly expanded. However,
our knowledge on the molecular changes that band 3
undergoes during aging in vivo, the effects of these
changes on binding of physiological, naturally
occurring autoantibodies, and on the induction of
pathological autoantibodies, has lagged behind. This
hampers a critical evaluation of claims on the
occurrence of erythrocyte aging during storage8-10.
Here we will review the data that are presently
available on changes in band 3 structure and function
during storage in blood bank conditions, focusing on
their relevance for the generation of immunological
removal signals as biomarkers of old and/or damaged
erythrocytes.
Changes in band 3 during storage
Various immunoblot data indicate progressive
alterations in band 3 structure during storage8, 11. These
data have been interpreted as indicating storage-
associated increases in breakdown and/or aggregation
of band 3 molecules (Figure 1A). The results obtained
with such immunoblot analyses depend not only on
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the use of denaturing conditions and on appropriate
gels for isolation and separation of high-molecular-
weight complexes, but also on the specificity of the
antibodies. This has been amply demonstrated, for
example in the case of antibodies against regions of
band 3 that carry Diego antigens12. In the latter study,
the virtual absence of staining of intact band 3,
together with the absence of storage-associated
changes using anti-Diego and anti-Wright antibodies
that were highly reactive in binding to intact
erythrocytes, illustrate once more the problem in
translating immunoblot data of integral membrane
proteins to structural information. This is corroborated
by the data from an extensive, semi-quantitative
proteomic analysis of the distribution of band 3
peptides over the molecular weight range from 15 -
300 kDa, that showed only a small increase in
aggregation and no significant changes in degradation
of band 3 with storage13. The relationship between
the band 3-containing aggregates and the oligomeric
state of band 3 in the membrane is unknown. However,
a recent spectroscopic study specifically attempting
to chart changes in the formation of oligomers in intact
erythrocytes during storage using eosin-5-maleimide,
also showed a minor increase in large oligomers, be
it after prolonged storage time14. It is unclear whether
the band 3-containing complexes of 150-250 kDa
consist of intact band 3 in a complex with other
proteins that has survived denaturation, or of
aggregates of band 3 degradation products. Mapping
of the peptides detected by mass spectrometry in the
various molecular weight fractions showed coverage
of the complete band 3 sequence (unpublished data),
which makes the former possibility more likely. One
of the proteins complexed with band 3 may very well
be haemoglobin, that is found in the same high
molecular weight fractions13, and that is strongly
associated with erythrocyte membranes after storage1.
Additional information was obtained by
immunoblot analyses of membrane fractions obtained
after treatment of intact erythrocytes with proteolytic
enzymes, following procedures that are commonly
used in blood group serology to make some blood
group antigens more accessible12. This approach has
yielded data that indicate an increased susceptibility
of band 3 to proteolytic degradation with storage time
(Figure 1B), associated with increased exposure of
epitopes that are involved in recognition of
erythrocytes aged in vivo by physiological
autoantibodies15. This increase is not only correlated
with an increase in the capacity to bind IgG upon
incubation with autologous plasma8 (Figure 2), but
also with an increase in erythrocyte-bound IgG,
probably as the result of the binding of IgG present in
the transfusion unit13, 16, 17. The specificity of this IgG
remains to be established, although the IgG fraction
eluted from stored erythrocytes has been used to
identify the extracellular loops of band 3 containing
residues 547-553 and 824-829 as crucial in the
recognition of old erythrocytes by physiological
autoantibodies7. This suggests that, during storage,
epitopes originate on band 3 that are identical or at
least immunologically related to the epitopes that
bestow senescent cell antigen activity upon
erythrocytes that have become old in vivo.
The relationship between storage-associated
alterations in band 3 structure and IgG binding is
confirmed by the finding that incubation of stored
erythrocytes with SITS, a high affinity ligand and
crosslinker of band 318, induced a storage time-
Figure 1 - Immunoblot analysis of membrane proteins from
erythrocytes of various storage times with anti-
band 3 antibodies.
Immunoblot analysis of erythrocytes stored for
the indicated periods (0, 16, 29, 36 days) was
performed with antibodies against the
membrane domain of band 3. +, membranes
isolated after incubation with papain. A,
increased breakdown and aggregation during
storage; B, increased susceptibility to proteolytic
breakdown with storage. The arrows indicate the
position of intact band 3.
Band 3 and erythrocyte storage
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associated increase in the binding of autologous IgG
(Figure 2). An identical, but (much) smaller effect was
observed with the structurally related band 3 ligands
and anion transport inhibitors DIDS and DNDS, that
have a much lower or no crosslinking activity,
respectively (data not shown). This suggests that the
storage-associated increase in autologous IgG binding
capacity is caused specifically by a storage-related
increase in the susceptibility of band 3 to crosslinking.
Treatment of freshly isolated erythrocytes with SITS
also increases the binding of antibodies against
senescent cell antigen-involved regions of band 319
from 1.3 to 3.0 percent of the erythrocytes. In addition,
the most dense erythrocytes, obtained by
discontinuous Percoll separation, are much more
sensitive to SITS-induced binding of autologous IgG
than the least dense erythrocytes15. Together, these data
suggest that there is a relationship between the
alterations in band 3 structure and organisation that
occur during storage, and those alterations that occur
during aging in vivo. An increase in IgG-binding
capacity also was observed upon artifical shrinkage,
but not by increased intracellular calcium
concentrations or by oxidation in vitro (Figure 2). The
latter results show that, although oxidation and
increasing the intracellular calcium concentration may
cause the same type of damage as accumulating during
storage, this damage does not cause immunologically
identical effects. Preliminary data suggest that the
sensitivity to these stressors may vary with donor
and/or transfusion unit (Bosman et al., in preparation).
Consequences of storage-associated changes
in band 3
Thus, storage-induced changes in band 3 structure
are associated with binding of autologous IgG in the
transfusion unit, and are likely to induce binding of
senescent cell-specific, autologous IgG after
transfusion to at least a fraction of the erythrocytes.
Alternatively, the central role of band 3 in the
organisation of the erythrocyte membrane implicates
that changes in band 3 structure may lead to loss of
recognition of self by the loss of CD47 activity, or
the generation of antigenic changes in Rhesus
proteins20, 21. In view of the preliminary data indicating
an increased susceptibility of band 3 on stored
erythrocytes to various treatments in vitro (Figures 1
and 2), we postulate that antigenic changes in band 3
structure will happen after transfusion as well. These
changes could very well be the result of the stress
that erythrocytes undergo during their passage through
the body, such as shrinkage by hyperosmotic shock,
oxidation by the constant binding and release of
oxygen, and increased calcium concentrations
resulting from loss of membrane integrity resulting
from deformation-induced mechanical stress22. This
may contribute to the fast removal of a considerable
fraction of the transfused erythrocytes2. Exposure of
senescent cell antigen-related epitopes on band 3 that
originate during storage or after transfusion may
induce the formation of neoantigens and new
antibodies, and eventually the development of
autoimmune haemolytic anaemia. Indeed, transfusions
are a risk factor for developing autoantibodies23,
mostly directed against targets on the Rhesus proteins
and the senescent cell antigen-associated regions of
band 324, 25.
The central role of band 3 in the maintenance of
erythrocyte shape is the cause of a causal link between
alterations in band 3 structure, erythrocyte
morphology, and cell deformability. Many mutations
Figure 2 - The effect of treatment of erythrocytes during
storage on the capacity to bind autologous IgG.
Erythrocytes of various storage periods were
subjected to incubation with hyperosmotic
medium inducing cell shrinkage, with
hydroperoxide inducing oxidation, with
ionomycin inducing an increase in intracellular
calcium concentration, and with SITS inducing
crosslinking of band 3 molecules. After these
treatments the cells were incubated with
autologous plasma and IgG binding was
determined by flowcytometry using FITC-
labeled anti-human IgG (Cappel). Hyperosmotic
shock and SITS induce an increase in IgG
binding starting at three weeks of storage.
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in band 3 are associated with an abnormal cell shape
as well as with haematological problems26. During
storage, morphological alterations are associated with
a decrease in deformability27, and with
immunochemical indications for altered membrane
and band 3 organisation10, 17. A loss of binding between
band 3 and the cytoskeleton may be responsible for
the storage-related increase in band 3 oligomerization
and/or aggregation13, 14, as well as for an increased
susceptibility to crosslinking (Figure 2). The decrease
in band 3-mediated linkage between lipid bilayer and
the cytoskeleton by itself could be enough to cause
release of vesicles28. Thus, changes in band 3 structure
are not only responsible for recognition by natural
autoantibodies but also for vesiculation. Vesicle
release in vivo is considered an integral part of the
physiological aging process, enabling the removal of
damaged membrane patches from otherwise
functional erythrocytes19. This theory is supported by
the observations that, during storage of erythrocytes
in transfusion units: 1, vesicle formation increases
strongly with storage time29; 2, vesicles are enriched
in modified haemoglobin species, including the
erythrocyte aging marker HbA1c15; 3, vesicles contain
much more aggregated as well as degraded band 3
than erythrocytes of the same storage time13; 4,
vesicles are enriched in strong removal signals such
as phosphatidylserine, IgG and complement
proteins13,15, 17.
Band 3 is involved in mediating
deoxyhaemoglobin-regulated erythrocyte metabolism
by phosphorylation-dependent binding of key
enzymes of the glycolysis30. Thus, band 3 alterations
during storage affect the binding between cytoskeleton
and lipid bilayer, as well as signaling of ATP, and
2,3-DPG production. The former will affect ion
homeostasis and cell deformability, and the latter
oxygen binding and release by haemoglobin. Both
effects will hamper the functional quality of the
erythrocytes after transfusion. Other processes may
become equally affected by changes in band 3
structure during storage. The close association
between glucose transporter and band 3 for example,
may explain the correlation between alterations in
band 3 structure and glucose transport characteristics
observed earlier20,31. This may also be true for the, as
yet mostly unknown, functions of the other
components of the band 3 complex.
It has been proposed that in pathological conditions
such as thalassemia, sickle cell disease, malaria and
G6PD deficiency, the first trigger for recognition by
naturally occurring anti-band 3 autoantibodies is
denatured haemoglobin-induced oxidation of band 3.
This would then be followed by tyrosine
phosphorylation of the cytoplasmic domain of band
3, thereby potentiating clustering and subsequent
neoantigen exposure32. It remains to be established if
this series of events also occurs during aging in vivo,
but all the observations summarized above suggest
that this mechanism may be operative during storage.
This would classify erythrocyte storage as a
pathological condition. In our opinion, future research
should focus on the prevention of the emergence of
these pathological erythrocytes in the erythrocyte
transfusion unit, and on their removal from the
transfusion unit before transfusion. Elucidation of the
molecular mechanisms of storage-associated changes
in band 3 is likely to be the most efficient way towards
this goal. The knowledge summarized here may
provide one set of tools in this endeavour, such as
erythrocyte fraction-specific antibodies and
functionally relevant markers for erythrocyte damage.
Another set of tools consists of the rapidly developing
methodology in the field of proteomics, especially
with respect to identifying and measuring
posttranslational modifications. We foresee that the first
inventories of the application of proteomics tools to the
research of blood components such as collected in this
issue, will contribute to the growth of our knowledge
on erythrocyte pathology, in vivo as well as in vitro.
Key words: band 3, erythrocyte, storage,
transfusion.
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